Taping for Saliva Control in Cerebral Palsy

NCT ID: NCT04252157

Last Updated: 2021-03-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-12-19

Study Completion Date

2021-03-17

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aim to investigate the effect of banding on saliva control and quality of life in children with cerebral palsy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cerebral palsy describes a whole set of permanent disorders or disorders in the development of movement and posture, attributed to non-progressive disorders occurring in the developing fetal or infant brain, causing activity limitation. Motor disorders are often accompanied by sensory, perception, communication and behavioral disorders, epilepsy and secondary musculoskeletal problems.

Kinesio Taping has been proven to increase local circulation, reduce local edema and provide a positional stimulus for muscle, skin, or facial structures, regulating sensory input, and activating regions in the brain. KT is currently used to improve oral control in children with neurological and neuromuscular disorders and provides a reduction in saliva flow and frequency. However, knowledge of the potential of using neuromuscular bandages to manage the dribble flow has been limited.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Palsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

kinesiotaping

Kinesotape will be apply with suitable tension and necessery region.

Group Type EXPERIMENTAL

Kinesiotaping

Intervention Type OTHER

Kinesiotape will be applied to the group. During the orbicularis oris muscle, I tape will be applied around the lip with a mechanical correction technique with 50-75% tension. I tape will be applied just below the Hyoid with a 50-75% tension mechanical correlation technique.

plesebo taping

Tape will be appy with randomly region without tension.

Group Type PLACEBO_COMPARATOR

Plesebo Taping

Intervention Type OTHER

An approximately 5 cm I tape will be applied to the group without applying any tension to the temporomandibular attachment for placebo taping.

control

Nothing will be applied

Group Type OTHER

Control

Intervention Type OTHER

no kinesio or tape will be applied

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Kinesiotaping

Kinesiotape will be applied to the group. During the orbicularis oris muscle, I tape will be applied around the lip with a mechanical correction technique with 50-75% tension. I tape will be applied just below the Hyoid with a 50-75% tension mechanical correlation technique.

Intervention Type OTHER

Plesebo Taping

An approximately 5 cm I tape will be applied to the group without applying any tension to the temporomandibular attachment for placebo taping.

Intervention Type OTHER

Control

no kinesio or tape will be applied

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being a dribble control disorder,
* Having a diagnosis of cerebral palsy,
* Being between the ages of 5-15,
* Not allergic to Kinesio Taping tape.

Exclusion Criteria

* Using drugs for saliva control disorder,
* Botulinum toxin has been applied in the last 6 months,
* Active infection (tooth, intestine, etc.),
* Failure to comply with treatment,
* Swallowing disorder.
Minimum Eligible Age

5 Years

Maximum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Baskent University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

aydan aytar

assoc. prof.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Aydan

Ankara, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

aydan aytar

Role: primary

+905071535028

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KA 19/316

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Kinesiotape and Dysphagia
NCT04750174 COMPLETED NA